Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Ten-year follow-up of unreplaced Valsalva sinuses after aortic valve replacement in bicuspid aortic valve disease 2019
2019 ESC working group on cellular biology of the heart: Position paper for Cardiovascular Research: Tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure 2019
2019 Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure 2019
2019 The effect of local anesthetic continuous wound infusion for the prevention of postoperative pneumonia after on-pump cardiac surgery with sternotomy: the STERNOCAT randomized clinical trial 2019
2018 Cell therapy trials for heart regeneration — lessons learned and future directions 2018
2018 Long-Term Engraftment (16 Years) of Myoblasts in a Human Infarcted Heart 2018
2018 Evaluation of a new model of hind limb ischemia in rabbits 2018
2018 Experimental Evaluation of Endovascular Fenestration Scissors in an Ovine Model of Aortic Dissection 2018
2018 Stem cell–derived exosomes and the failing heart: Small cause, big effect 2018
2018 Multiple reoperations on the aortic valve: Outcomes and implications for future potential valve-in-valve strategy 2018
2018 Acellular therapeutic approach for heart failure: In vitro production of extracellular vesicles from human cardiovascular progenitors 2018
2018 Will cardiac surgeons even turn pumpkins into carriages? 2018
2018 Extracellular vesicles: new therapeutic agents for cardiac repair ? 2018
2018 The influence of electrospinning parameters on polydioxanone scaffold properties 2018
2018 Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction 2018
2018 Global overview of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) Recommendations: A comprehensive series of challenges and priorities of cardiovascular regenerative medicine 2018
2018 Intra-cardiac release of extracellular vesicles shapes inflammation following myocardial infarction short communication 2018
2018 Platelet vesicles help cardiac stem cells engraft 2018
2018 Thermoresponsive Gel Embedded with Adipose Stem-Cell-Derived Extracellular Vesicles Promotes Esophageal Fistula Healing in a Thermo-Actuated Delivery Strategy 2018
2017 A 3D magnetic tissue stretcher for remote mechanical control of embryonic stem cell differentiation 2017
2017 Bone marrow-derived mesenchymal stem cell-loaded fibrin patches act as a reservoir of paracrine factors in chronic myocardial infarction 2017
2017 Cell therapy in heart failure:where do they stand? 2017
2017 The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial 2017
2017 The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: Update 2016 2017
2017 RGD constructs with physical anchor groups as polymer co-electrospinnable cell adhesives 2017
2017 Awareness of Individual Cardiovascular Risk Factors and Self-Perception of Cardiovascular Risk in Women 2017
2017 Global position paper on cardiovascular regenerative medicine 2017
2017 Effect of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass - The LICORN randomized clinical trial 2017
2017 Do not throw the baby with the water bath! 2017
2017 HEMO2life as a protective additive to Celsior solution for static storage of donor hearts prior to transplantation 2017
2017 Building a bioartificial heart: A 3-song saga 2017
2017 Fibers for hearts: A critical review on electrospinning for cardiac tissue engineering 2017
2016 CD133+ cells: How could they have an IMPACT? 2016
2016 Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study) 2016
2016 The future of stem cells: Should we keep the “stem” and skip the “cells”? 2016
2016 The TACTICS initiative: Time for a Global Alliance on Cardiovascular Regenerative Medicine 2016
2016 Distilling complexity to advance cardiac tissue engineering 2016
2016 Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure 2016
2016 Chitosan Hydrogels for the Regeneration of Infarcted Myocardium: Preparation, Physicochemical Characterization, and Biological Evaluation 2016
2016 Stem cells for the treatment of heart failure 2016
2016 Control of Immune Response to Allogeneic Embryonic Stem Cells by CD3 Antibody-Mediated Operational Tolerance Induction 2016
2016 Inhibition of factor ixa by the pegnivacogin system during cardiopulmonary bypass: A potential substitute for heparin. a study in baboons 2016
2016 Nanofibrous clinical-grade collagen scaffolds seeded with human cardiomyocytes induces cardiac remodeling in dilated cardiomyopathy 2016
2016 Mast cells regulate myofilament calcium sensitization and heart function after myocardial infarction 2016
2015 The Evolution of the Stem Cell Theory for Heart Failure 2015
2015 Stem cells for the treatment of heart failure 2015
2015 Long-term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold 2015
2015 Fabrication of cardiac patch by using electrospun collagen fibers 2015
2015 Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: First clinical case report 2015
2015 Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: A translational experience 2015
2015 Stem cells in the management of advanced heart failure 2015
2015 Comparative Analysis of Methods to Induce Myocardial Infarction in a Closed-Chest Rabbit Model 2015
2015 Concise review: Growing hearts in the right place: On the design of biomimetic materials for cardiac stem cell differentiation 2015
2015 Guidelines for Translational Research in Heart Failure 2015
2015 Polymer-based reconstruction of the inferior vena cava in rat: Stem cells or RGD peptide? 2015
2014 Predictors of contemporary coronary artery bypass grafting outcomes 2014
2014 How Close Are We to Using Stem Cells in Routine Cardiac Therapy? 2014
2014 Atrial fibrillation at mid-term after bioprosthetic aortic valve replacement: Implications for anti-thrombotic therapy 2014
2014 Effect of severe acidosis on vasoactive effects of epinephrine and norepinephrine in human distal mammary artery 2014
2014 Long-term functional benefits of Epicardial patches as cell carriers 2014
2013 Efficacy of epicardially delivered adipose stroma cell sheets in dilated cardiomyopathy 2013
2013 An egg-shaped cyst of the right interventricular septum 2013
2013 Adenosine in heart transplants: Have we finally found the good indication? 2013
2013 Tissue engineering and reconstruction of the right ventricular outflow tract 2013
2013 Cost-effectiveness of mitral valve repair versus replacement by biologic or mechanical prosthesis 2013
2012 Comprehensive annular and subvalvular repair of chronic ischemic mitral regurgitation improves long-term results with the least ventricular remodeling 2012
2012 Third universal definition of myocardial infarction 2012
2012 Third universal definition of myocardial infarction. 2012
2012 Embryonic stem cells for severe heart failure: Why and how? 2012
2012 Third universal definition of myocardial infarction 2012
2012 Repairing broken hearts and damaged vessels 2012
2012 Immune response to human embryonic stem cell-derived cardiac progenitors and adipose-derived stromal cells. 2012
2012 Embryonic stem cells in the treatment of severe cardiac insufficiency 2012
2012 Prevention of postcardiopulmonary bypass pericardial adhesions by a new resorbable collagen membrane 2012
2012 Can magnetic targeting of magnetically labeled circulating cells optimize intramyocardial cell retention? 2012
2012 Gene polymorphisms and cytokine plasma levels as predictive factors of complications after cardiopulmonary bypass 2012
2012 Mitral valve reconstruction in Barlow disease: Long-term echographic results and implications for surgical management 2012
2012 Vodka to prevent postoperative adhesions: Another unsuspected cardiac benefit of alcohol 2012
2011 Consequences of mitral valve prolapse on chordal tension: Ex vivo and in vivo studies in large animal models 2011
2011 The heart 2011
2011 Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections 2011
2011 A dream came true 2011
2011 Cardiac cell therapy: Lessons from clinical trials 2011
2011 Stem cell therapy for chronic heart failure. Lessons from a 15-year experience 2011
2010 Relief of mitral leaflet tethering following chronic myocardial infarction by chordal cutting diminishes left ventricular remodeling 2010
2010 Cell therapy for peripheral arterial disease 2010
2010 Composite cell sheets: A further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells 2010
2010 Galectin-1 and semaphorin-3A are two soluble factors conferring t-cell immunosuppression to bone marrow mesenchymal stem cell 2010
2010 A polydioxanone electrospun valved patch to replace the right ventricular outflow tract in a growing lamb model 2010
2010 A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates 2010
2010 Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration. A Report of the International Society for Cardiovascular Translational Research 2010
2010 A new absorbable collagen membrane to reduce adhesions in cardiac surgery 2010
2009 Cell therapy: Results in cardiology 2009
2009 Stem cell therapy for heart failure: Are arrhythmias a real safety concern? 2009
2009 Cell Delivery: Intramyocardial Injections or Epicardial Deposition? A Head-to-Head Comparison 2009
2009 Cell-based therapy for heart disease: A clinically oriented perspective 2009
2009 Does the human skeletal muscle harbor the murine equivalents of cardiac precursor cells? 2009
2009 Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells? 2009
2009 The place of stem cells in the treatment of cardiopathies 2009
2008 Skeletal Myoblasts for Cardiac Repair: Act II? 2008
2008 Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium 2008
2008 Myocardial revascularization thirty years after: Surgery is still up to date 2008
2008 Self-assembling peptide nanofibers and skeletal myoblast transplantation in infarcted myocardium 2008
2008 Skeletal myoblasts and cardiac repair 2008
2008 Reply to the Editor: 2008
2008 Towards the second generation of skeletal myoblasts? 2008
2008 Current Status and Future Prospects for Cell Transplantation to Prevent Congestive Heart Failure 2008
2008 Efficacy and safety of pyridoxal 5′-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: The MEND-CABG II randomized clinical trial 2008
2008 Myoblast autologous grafting in ischemic cardiomyolmthy (MAGIC) 2008
2008 Sodium-Hydrogen Exchange Inhibition by Cariporide to Reduce the Risk of Ischemic Cardiac Events in Patients Undergoing Coronary Artery Bypass Grafting: Results of the EXPEDITION Study 2008
2008 Cardiac stem cells in the real world 2008
2008 Reply to "GFP fails to inhibit actin-myosin interactions in vitro" [3] 2008
2008 Cardiac cell therapy trials: chronic myocardial infarction and congestive heart failure. 2008
2008 Challenging the cardiac differentiation of bone marrow cells: A clinical perspective 2008
2008 Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium. 2008
2008 The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation 2008
2007 Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats 2007
2007 Primitive neuroectodermal tumor of the myometrium with cardio-vascular symptoms 2007
2007 Skeletal Myoblasts as a Therapeutic Agent 2007
2007 Can erythropoietin improve skeletal myoblast engraftment in infarcted myocardium? 2007
2007 Cellular therapy in cardiology 2007
2007 Construction of skeletal myoblast-based polyurethane scaffolds for myocardial repair 2007
2007 Erratum to "Cord blood and myocardial infarction: An uncertain wedding" [J. Mol. Cell. Cardiol. 42 (2007) 727-729] (DOI:10.1016/j.yjmcc.2007.02.006) 2007
2007 Perspectives in cardiac cell therapy 2007
2007 Green fluorescent protein impairs actin-myosin interactions by binding to the actin-binding site of myosin 2007
2007 Cellular therapy in thoracic and cardiovascular disease. 2007
2007 Cord blood and myocardial infarction: An uncertain wedding 2007
2007 Is xenotransplantation of embryonic stem cells a realistic option? 2007
2007 Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization 2007
2007 Perspectives in cardiac cell therapy 2007
2006 Myoblast transplantation during cardiac surgery 2006
2006 Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium? 2006
2006 Effect of Pexelizumab in Coronary Artery Bypass Graft Surgery With Extended Aortic Cross-Clamp Time 2006
2006 Chordal cutting does not adversely affect left ventricle contractile function 2006
2006 Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure 2006
2006 Skeletal myoblast transplantation in ischemic heart failure: Long-term follow-up of the first phase I cohort of patients 2006
2006 Erratum: GFP expression in muscle cells impairs actin-myosin interactions: Implications for cell therapy (Nature Methods (2006) vol. 3 (331)) 2006
2006 The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart 2006
2006 [Risk-benefit of same-day combined coronary surgery]. 2006
2006 Autologous Myoblast Transplantation for Chronic Ischemic Mitral Regurgitation 2006
2006 GFP expression in muscle cells impairs actin-myosin interactions: Implications for cell therapy 2006
2006 The 16th European Meetings of the SFC 2006 2006
2006 Routine delivery of myoblasts during coronary artery bypass surgery: Why not? 2006
2006 You can't judge a book by its cover 2006
2006 Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery 2006
2005 Stem cell therapy for myocardial regeneration: Creating hype ignoring reality [1] (multiple letters) 2005
2005 Cell-based cardiac repair reflections at the 10-year point 2005
2005 Stem cells for clinical use in cardiovascular medicine: Current limitations and future perspectives 2005
2005 Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: A preclinical study 2005
2005 Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium? 2005
2005 Stem cell research and cell transplantation for myocardial regeneration 2005
2005 The potential of embryonic stem cells to treat heart disease 2005
2005 Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1α 2005
2005 Myocardial injection of myoblasts 2005
2005 Myoblast transplantation for heart failure: Where are we heading? 2005
2005 Skeletal myoblast for cell therapy 2005
2005 Cardiac cellular therapy: from cells to the first clinical uses 2005
2005 Myoblast transplantation for heart failure: where are we heading? 2005
2005 Na +/H + exchange inhibition in hypertrophied myocardium subjected to cardioplegic arrest: An effective cardioprotective approach 2005
2005 Role of stem cells in cardiac repair 2005
2005 Skeletal myoblast transplantation through a catheter-based coronary sinus approach: An effective means of improving function of infarcted myocardium 2005
2004 Overcoming bacterial DNA contamination in real-time PCR and RT-PCR reactions for LacZ detection in cell therapy monitoring 2004
2004 Embryonic stem cells pace the heart 2004
2004 Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? 2004
2004 Comparison of human skeletal myoblasts and bone marrow-derived CD133 + progenitors for the repair of infarcted myocardium 2004
2004 Cellular transplantation: Hurdles remaining before widespread clinical use 2004
2004 Bentall intervention: 15 Years later 2004
2004 Myoblast transfer in heart failure 2004
2004 Skeletal myoblast transplantation for cardiac repair 2004
2003 Stem cells: Where we stand 2003
2003 [Totally implantable artificial heart: a new stage]. 2003
2003 Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation 2003
2003 Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation. 2003
2003 Transplantation of autologous fresh bone marrow into infarcted myocardium: A word of caution 2003
2003 Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. 2003
2003 Myoblast-based cell transplantation 2003
2003 Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host 2003
2003 Cell transplantation in myocardium 2003
2003 Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat 2003
2003 Skeletal muscle satellite cell transplantation 2003
2003 Stem cells in the treatment of ischemic heart failure 2003
2003 Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy 2003
2003 Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction 2003
2003 Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy 2003
2003 Cell therapy for heart failure 2003
2002 Cell transplantation for post-ischemic heart failure 2002
2002 Myoblast transplantation for the treatment of heart failure 2002
2002 Myoblast transplantation: Feasibility, safety and efficacy 2002
2002 [Myocardial implantation of muscle cells]. 2002
2002 Surgical treatments and transplantations in the management of heart failure 2002
2002 [Surgical treatment and transplantation in heart failure]. 2002
2002 Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction 2002
2002 Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. 2002
2002 Proinflammatory and antiinflammatory cytokines after cardiac operation: Different cellular sources at different times. Invited commentary 2002
2002 Is there a place for preconditioning during cardiac operations in humans? 2002
2002 Invited commentary 2002
2002 Cell therapy of heart failure 2002
2002 Cell therapy: myoblast autograft 2002
2002 Cell transplantation for the treatment of heart failure 2002
2002 Cellular myoplasty: What are we really trying to achieve? [3] (multiple letters) 2002
2002 Cellular transplantation for the treatment of heart failure. 2002
2002 Cellular transplantation in the treatment of ischaemic heart failure 2002
2001 Temperature and inflammatory response on cardiopulmonary bypass 2001
2001 The postoperative period in cardiac surgery 2001
2001 The systemic factor: The comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery 2001
2001 Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors? 2001
2001 Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors? 2001
2001 Backtable heat-enhanced preconditioning: A simple and effective means of improving function of heart transplants 2001
2001 Can statins reduce the inflammatory response to cardiopulmonary bypass? A clinical study. 2001
2001 Preconditioning protects the severely atherosclerotic mouse heart: Invited commentary 2001
2001 Factors affecting functional outcome after autologous skeletal myoblast transplantation 2001
2001 [Autologous skeletal myoblast transplantation for cardiac insufficiency. First clinical case]. 2001
2001 Myoblast transplantation for heart failure 2001
2001 Pressure-adjusted antegrade brain perfusion for surgery of the aortic aneurysm 2001
2001 Ischemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels or Na+/H+ exchange inhibition: Which is the best protective strategy for heart transplants? 2001
2001 Myoblast transplantation for heart failure 2001
2001 Panel discussion: Monitoring and improving patient safety during and following cardiac surgery 2001
2001 Regeneration of the myocardium: A new role in the treatment of ischemic heart disease? 2001
2001 Strategies to improve myocardial protection during extracorporeal circulation 2001
2000 Cellular cardiomyoplasty: A new hope in heart failure? 2000
2000 Intramyocardial transplantation of autologous myoblasts: Can tissue processing be optimized? 2000
2000 Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized? 2000
2000 Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery? 2000
2000 Opening of mitochondrial potassium channels: A new target for graft preservation strategies? 2000
2000 Ministernotomy for aortic valve replacement: A study of the preliminary experience 2000
2000 Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury 2000
2000 Cardioplegic solution challenges. 2000
2000 Cell therapy: A potential new tool for treating severe ischemic left ventricular dysfunction 2000
2000 Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function 2000
2000 Réaction anaphylactique à l’aprotinine: Intérêt diagnostique des tests intradermiques 2000
2000 Thoracic organ preservation 2000
1999 On 'effect of partial oxygen supply on mitochondrial electron transport system during complete cardiac ischemia' 1999
1999 Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery 1999
1999 Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. 1999
1999 Preconditioning by mitochondrial ATP-sensitive potassium channel openers: An effective approach for improving the preservation of heart transplants 1999
1999 Preconditioning by mitochondrial ATP-sensitive potassium channel openers: An effective approach for improving the preservation of heart transplants. 1999
1999 Preconditioning: Can nature's shield be raised against surgical ischemic-reperfusion injury? 1999
1999 [Coronary surgery in the stenting era]. 1999
1999 Opening of potassium channels the common cardioprotective link between preconditioning and natural hibernation? 1999
1999 Donor management, organ preservation, organ distribution coronary endothelial dysfunction of isolated hearts subjected to prolonged cold storage: Patterns and contributing factors 1999
1999 Endothelial effects of hemostatic devices for continuous cardioplegia or minimally invasive operations 1999
1999 Favorable aspect of stapled anastomosis: An endothelial function study [7] 1999
1999 High-flow gas insufflation to facilitate MIDCAB [4] 1999
1999 Protective effects of Celsior in lung transplantation 1999
1998 Cellular cardiomyoplasty: State of the art, evaluation and future possibilities 1998
1998 Nonpenetrating stapling: A valuable alternative for coronary anastomoses? 1998
1998 Can cellular transplantation improve function in doxorubicin-induced heart failure? 1998
1998 Can cellular transplantation improve function in doxorubicin-induced heart failure? 1998
1998 Inhibition of the pacemaker current: A bradycardic therapy for off-pump coronary operations 1998
1998 [Coronary surgery on the beating heart under extracorporeal circulation in high-risk patients. An acceptable compromise?]. 1998
1998 Is myocardial stunning of clinical importance? A surgeon's perspective 1998
1998 On 'posterior ventricular septal rupture: An anatomical reconstruction': Commentary 1998
1997 Failure of preconditioning to improve postcardioplegia stunning of minimally infarcted hearts 1997
1997 Ischemic preconditioning before normothermic retrograde cardioplegia [6] (multiple letters) 1997
1997 Role of preconditioning in cardiac surgery 1997
1997 Does transplantation of cardiomyocytes improve function of infarcted myocardium? 1997
1997 Does transplantation of cardiomyocytes improve function of infarcted myocardium? 1997
1997 On-pump, beating-heart coronary artery operations in high-risk patients: An acceptable trade-off? 1997
1997 Protective effect of reduced glutathione on endothelial function of coronary arteries subjected to prolonged cold storage 1997
1997 Warm blood cardioplegia in high risk patients 1997
1997 Heart valve homografts 1997
1997 Simplified technique for antegrade cerebral perfusion 1997
1997 Snaring of the target vessel in less invasive bypass operations does not cause endothelial dysfunction 1997
1997 Is warm retrograde blood cardioplegia better than cold for myocardial protection?: Invited commentary 1997
1997 New strategies in myocardial preservation 1997
1997 [Valvular homografts]. 1997
1996 Can grafted cardiomyocytes colonize peri-infarct myocardial areas? 1996
1996 Can grafted cardiomyocytes colonize peri-infarct myocardial areas? 1996
1996 Evidence for an involvement of the neutrophil integrin lymphocyte function-associated antigen-1 in early failure of heart transplants 1996
1996 Evidence for an involvement of the neutrophil integrin lymphocyte function-associated antigen-1 in early failure of heart transplants. 1996
1996 Endogenous myocardial protection 1996
1996 Poststorage diastolic abnormalities of heart transplants: Is vascular dysfunction or myocardial contracture the culprit? 1996
1996 Endogenous myocardial protection 1996
1996 Blood cardioplegia: Do we still need to dilute? 1996
1996 Cardioprotective Effect of Desferrioxamine 1996
1996 Endothelial effects of hemostatic devices for continuous cardioplegia or minimally invasive operations 1996
1996 Is potassium channel opening an effective form of preconditioning before cardioplegia? 1996
1996 Ischemic preconditioning in cardiac surgery: A word of caution 1996
1996 Patterns of changes in neutrophil adhesion molecules during normothermic cardiopulmonary bypass: A clinical study 1996
1995 The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function 1995
1995 Hypothermia during cardiopulmonary bypass delays but does not prevent neutrophil-endothelial cell adhesion. A clinical study. 1995
1995 Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass 1995
1995 Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass. 1995
1995 [Does temperature in extracorporeal circulation affect neutrophil-endothelium interactions?]. 1995
1995 Evaluation of a new preservation solution: Celsior in the isolated rat lung 1995
1995 Evaluation of a new preservation solution: Celsior in the isolated rat lung. Paris-Sud University Lung Transplatation Group. 1995
1995 Acadesine: A new drug that may improve myocardial protection in coronary artery bypass grafting. Results of the first international multicenter study 1995
1995 Does the temperature of cardiopulmonary bypass affect neutrophil interactions with the endothelium? 1995
1995 Hypothermia during cardiopulmonary bypass delays but does not prevent neutrophil-endothelial cell adhesion: A clinical study 1995
1995 Preconditioning with potassium channel openers:. A new concept for enhancing cardioplegic protection? 1995
1995 Ultrasonic dissection: A useful adjunct to operation for calcified constrictive pericarditis 1995
1995 Valvular allotransplantation 1995
1994 Does normothermia during cardiopulmonary bypass increase neutrophil-endothelium interactions? 1994
1994 Does normothermia during cardiopulmonary bypass increase neutrophil-endothelium interactions? 1994
1994 Metabolic and functional evidence that retrograde warm blood cardioplegia does not injure the right ventricle in human beings. 1994
1994 Direct assessment of the antioxidant effects of a new heart preservation solution, celsior: A hemodynamic and electron spin resonance study 1994
1994 Experimental comparison of manually inflatable versus autoinflatable retrograde cardioplegia catheters 1994
1994 Warm cardioplegia or aerobic cardioplegia? Let's call a spade a spade 1994
1994 [Pericardial constriction caused by epicardial patches of automatic implantable defibrillators. Apropos of 3 cases]. 1994
1994 Retrograde warm blood cardioplegia preserves hypertrophied myocardium: A clinical study 1994
1994 Invited commentary 1994
1994 A potential mechanism of vasodilation after warm heart surgery: The temperature-dependent release of cytokines 1994
1994 A potential mechanism of vasodilation after warm heart surgery: the temperature-dependent release of cytokines. 1994
1994 Experimental evaluation of celsior, a new heart preservationsolution 1994
1994 Metabolic and functional evidence that retrograde warm blood cardioplegia does not injure the right ventricle in human beings 1994
1994 Pericardial constriction due to epicardial patch electrodes of implantable automatic defibrillators: Three case reports 1994
1994 Reply 1994
1993 Efficacy of lactobionate-enriched cardioplegic solution in preserving compliance of cold-stored heart transplants 1993
1993 Retrograde continuous normothermic blood cardioplegia during heart transplantation 1993
1993 Efficacy of lactobionate-enriched cardioplegic solution in preserving compliance of cold-stored heart transplants. 1993
1993 Acute massive postoperative atrial thrombosis in a patient undergoing low molecular weight heparin anticoagulation 1993
1993 Coronary sinus retroperfusion for myocardial protection: pragmatic observations and caveats based on a large experience. 1993
1993 Improved recovery of heart transplants with a specific kit of preservation solutions 1993
1993 Limitation of vasodilation associated with warm heart operation by a "mini-cardioplegia" delivery technique 1993
1993 Simplified method for delivering normothermic blood cardioplegia 1993
1993 Triiodothyronine therapy in open-heart surgery: From hope to disappointment 1993
1992 [Early constrictive pericarditis after coronary revascularization. Apropos of a case]. 1992
1992 1985: Fluorocarbons: A potential treatment of cerebral air embolism in open-heart surgery 1992
1992 Early constrictive pericarditis after coronary bypass surgery: A case report 1992
1992 Is the internal mammary artery an acceptable graft in the elderly patients with left main coronary artery disease? 1992
1992 Maintenance of the myocardial thiol pool by N-acetylcysteine: An effective means of improving cardioplegic protection 1992
1992 Normothermic cardioplegia: Is aortic cross-clamping still synonymous with myocardial ischemia? 1992
1992 Pretreatment with captopril improves myocardial recovery after cardioplegic arrest 1992
1992 Towards an integrated protection of heart grafts 1992
1991 [Retrograde cardioplegia through the coronary sinus in the surgery of the aortic valve. A clinical study of 500 patients]. 1991
1991 Cardioplegia by way of the coronary sinus for valvular and coronary surgery 1991
1991 Efficacy of coronary sinus cardioplegia in patients with complete coronary artery occlusions 1991
1991 Fluorocarbon cardioplegia revisited: Sustained efficacy, easier handling, and improved biocompatibility. A P-31 NMR assessment on the isolated perfused rat heart 1991
1991 Limitation of free radical injury by reduced glutathione: An effective means of improving the recovery of heart transplants 1991
1991 Retrograde coronary sinus cardioplegia for aortic valve surgery. A clinical trial in 500 patients 1991
1991 The surgical section of the bundle of Kent as an operative treatment of the Wolff-Parkinson-White syndrome: apropos a series of 82 operated cases 1991
1990 Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans 1990
1990 Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans. 1990
1990 Use of the acyl azide method for cross-linking collagen-rich tissues such as pericardium. 1990
1990 A promising approach for improving the recovery of heart transplants. Prevention of free radical injury through iron chelation by deferoxamine 1990
1990 Continuous arteriovenous hemodialysis for acute renal failure after cardiac operations 1990
1990 Floating left atrial thrombus in two cases of severe mitral stenosis 1990
1990 Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans 1990
1990 Retrograde coronary sinus cardioplegia for aortic valve operations: A clinical report on 500 patients 1990
1990 Role of angioplasty in the treatment of arteritis of the lower limbs 1990
1989 Adequate preservation of right ventricular function after coronary sinus cardioplegia. A clinical study. 1989
1989 [Aortic and mitral endocarditis caused by Haemophilus paraphrophilus with abscess of the aortic ring and cerebral embolism]. 1989
1989 [Role of calcium blockers in protecting the myocardium in cardiac surgery]. 1989
1989 Adequate preservation of right ventricular function after coronary sinus cardioplegia. A clinical study 1989
1989 Aortic and mitral Haemophilus paraphrophilus endocarditis with abscess of the aortic annulus and cerebral embolism 1989
1989 Enzyme release and mitochondrial activity in reoxygenated cardiac muscle: relationship with oxygen-induced lipid peroxidation. 1989
1989 Free radicals and myocardial protection: A surgical viewpoint 1989
1989 Protective effects of calcium channel blockers in cardiac surgery 1989
1989 Surgery for the Wolff-Parkinson-White syndrome in 73 consecutive patients: what have we learnt from intraoperative mapping? 1989
1989 Utilization of Laser Arterial Angioplasty 1989
1989 Utilization of laser arterial angioplasty. 1989
1988 Cardioplegic arrest superimposed on evolving myocardial ischemia. Improved recovery after inhibition of hydroxyl radical generation by peroxidase or deferoxamine. A 31P nuclear resonance study. 1988
1988 A new concept of cardioplegic protection in heart surgery: Iron chelation 1988
1988 Cardioplegic arrest superimposed on evolving myocardial ischemia. Improved recovery after inhibition of hydroxyl radical generation by peroxidase of deferoxamine. A 31P nuclear resonance study 1988
1988 Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man 1988
1988 Rupture of the right ventricular free wall an unusual complication of mediastinitis after cardiac surgery 1988
1987 Clinical use of automatic implantable defibrillators 1987
1987 [Myocardial toxicity of free radicals of oxygen during the ischemia-revascularization sequence. A re-assertion]. 1987
1987 Prevention of hydroxyl radical formation: a critical concept for improving cardioplegia. Protective effects of deferoxamine. 1987
1987 [Brucella endocarditis with favorable development after early heart valve replacement]. 1987
1987 Clinical use of automatic implantable defibrillators. 1987
1987 Surgery in the Wolff-Parkinson-White syndrome: Value of the epicardial approach; results in 28 operated cases 1987
1987 Alpha-myosin heavy chain isoform and atrial size in patients with various types of mitral valve dysfunction: A quantitative study 1987
1987 Decreased incidence of supraventricular arrhythmias achieved by selective atrial cooling during aortic valve replacement 1987
1987 Long term clinical results of implantable automatic defibrillators 1987
1987 Long-term Results of Emergency Surgery for Postinfarction Ventricular Septal Defect 1987
1987 Retrograde Cardioplegia Through the Coronary Sinus 1987
1987 [Surgery of Wolff-Parkinson-White: value of the epicardial approach. Apropos of 28 surgically treated cases]. 1987
1986 Enhancement of cardioplegic protection with the free-radical scavenger peroxidase 1986
1986 [Retrograde cardioplegia through the coronary sinus]. 1986
1986 Enhancement of cardioplegic protection with the free-radical scavenger peroxidase. 1986
1986 [Free radical scavenging agents in myocardial protection during cardiac surgery]. 1986
1986 The effects of retrograde perfusion of cardioplegic solutions in cardiac operations. 1986
1986 Anatomic bases of the surgical division of Kent bundles in the posterior septal area of the heart 1986
1986 What to do about an asymptomatic carotid artery stenosis 1986
1986 Pulsed laser in in vitro coronary recanalization 1986
1986 A comparative study of free radical scavengers in cardioplegic solutions. Improved protection with peroxidase 1986
1986 Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: Relation to hemodynamic effects in surgical patients 1986
1986 Fluorocarbon Treatment for Cerebral Air Embolism: Reply 1986
1986 Protective effects of anti-oxygen free radical agents on ischaemic and reperfused hearts: Applications in cardioplegia 1986
1986 [Treatment of renal cancer extending supradiaphragmatically with fibrinolytics following surgery under extracorporeal circulation, hypothermia and circulatory arrest]. 1986
1985 [In vitro opening of human atheromatous coronary arteries using a pulsed laser]. 1985
1985 Influence of the pH of cardioplegic solutions on intracellular pH, high-energy phosphates, and postarrest performance. Protective effects of acidotic, glutamate-containing cardioplegic perfusates 1985
1985 Effect of nifedipine in hypothermic cardioplegia: a phosphorus-31 nuclear magnetic resonance study 1985
1985 Limitations of fluorocarbons in reducing myocardial infarct size 1985
1985 Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations 1985
1985 Enhanced cardioplegic protection by a fluorocarbon-oxygenated reperfusate: A phosphorus-31 nuclear magnetic resonance study 1985
1985 Fluorocarbons: A Potential Treatment of Cerebral Air Embolism in Open-Heart Surgery 1985
1985 Increased injury of hypertrophied myocardium with ischemic arrest: Preservation with hypothermia and cardioplegia 1985
1985 On “Effect of Partial Oxygen Supply on Mitochondrial Electron Transport System During Complete Cardiac Ischemia” 1985
1985 P-NMR study of high-energy phosphorylated compounds metabolism and intracellular ph in the perfused rat heart 1985
1985 Results of surgery in W.P.W. syndrome 1985
1984 Collagen vascular grafts: A step towards improved compliance in small-calibre bypass surgery; preliminary report 1984
1984 Protective effects of cardioplegia on diastolic function of hypertrophied rat hearts after hypothermic ischaemic arrest 1984
1984 Protective effects of cardioplegia on diastolic function of hypertrophied rat hearts after hypothermic ischaemic arrest. 1984
1984 An asanguineous reperfusion solution. An effective adjunct to cardioplegic protection in high-risk valve operations 1984
1984 Reduction of myocardial infarct size by a fluorocarbon-oxygenated reperfusate 1984
1984 Protective Effect of an Asanguineous Reperfusion Solution on Myocardial Performance Following Cardioplegic Arrest 1984
1984 Radionuclide assessment of cardiac function: Pre‐operative evaluation of patients with abdominal aortic occlusive disease undergoing aortobifemoral bypass grafting 1984
1983 [Ionic bases of cardioplegic solutions. II. Influence of the ionic composition of a cardioplegic solution on the metabolic and functional preservation of ischemic myocardium. Experimental evaluation with phosphorus 31 nuclear magnetic resonance and applications to cardiac surgery]. 1983
1983 Long term results of vascular prosthesis in the treatment of aortoiliac stenosing lesions 1983
1983 [The implantable automatic defibrillator. Preventive treatment of sudden death caused by ventricular arrhythmia]. 1983
1983 [Acute rupture of the left ventricle 12 hours after an anteroseptal myocardial infarct. Successful surgical repair]. 1983
1983 Applications of a perfluorocarbon to heart ischemia. 1983
1983 Coronary artery spasm during non‐cardiac surgical procedure 1983
1983 Evaluation of high-energy phosphate metabolism during cardioplegic arrest and reperfusion: A phosphorus-31 nuclear magnetic resonance study 1983
1982 Coarctations of the thoracoabdominal aorta. Problems of surgical management 1982
1982 Nuclear magnetic resonance: A new method for non-invasive assessment of cardiac metabolism 1982
1982 [Aorto-left ventricular discontinuity of infectious origin. Problems of surgical repair]. 1982
1982 [Fluorocarbons: applications to cardiovascular surgery (author's transl)]. 1982
1982 [Nuclear magnetic resonance. Applications to medicine and biology (author's transl)]. 1982
1982 Acute left ventricular rupture secondary to myocardial infarction. Report of long-term survival after early surgical repair. 1982
1982 Beneficial effects of nifedipine on cardiac metabolism and function after cardioplegic arrest. A phosphorus-31 nuclear magnetic resonance study 1982
1982 Nuclear magnetic resonance. Applications to medicine and biology 1982
1982 Retrograde Coronary Sinus Perfusion: A Safe Alternative for Ensuring Cardioplegic Delivery in Aortic Valve Surgery 1982
1982 [P31 nuclear magnetic resonance: a new technique for the evaluation of myocardial protection]. 1982
1981 [Applications of carbon to cardiovascular biotechnology (author's transl)]. 1981
1981 [Mechanical or biological prostheses in valvular substitutes (author's transl)]. 1981
1981 [A new method to evaluate myocardial preservation techniques (author's transl)]. 1981
1981 Limitations of Potassium Cardioplegia during Cardiac Ischemic Arrest: A Phosphorus 31 Nuclear Magnetic Resonance Study 1981
1981 Regional blood flow during pulsatile and nonpulsatile cardiopulmonary bypass 1981
1980 [Congenital aorto-pulmonary window. Results of operation after 3 to 20 years in ten cases (author's transl)]. 1980
1980 Congenital aorto-pulmonary window. Results of operation after 3 to 20 yr in 10 cases 1980
1979 Surgical treatment of Prinzmetal's syndrome. Report of sixty operated cases 1979
1979 [Postoperative haemodynamic evaluation of myocardial protection by physicochemical cardioplegia. Hyperkaliemic, hyperosmolar and acid solution at 4 degrees C (author's transl)]. 1979
1978 Surgical treatment of Prinzmetal's syndrome. Report of 60 operated cases (author's transl) 1978
1978 [Remote results of the surgical correction of aortic coarctation. Study of 90 patients operated on 11 to 15 years earlier]. 1978
1978 Evaluation of coronary flush during myocardial protection : two hours aortic clamping in the dog. Early and late results (author's transl) 1978
1978 Long-term results of surgical treatment of coarctation of the aorta. A study of 90 patients between 11 and 15 years after operation 1978
1977 [Closed-heart mitral commissurotomy. Twenty years after]. 1977
1977 [Acute cardiac insufficiency after extracorporeal circulation : methods and current indications for cardiac compensation (author's transl)]. 1977
1977 Assisted respiration with the membrane oxygenator: surgical problems (author's transl) 1977
1976 [The external laryngeal nerve. Possible danger of thyroid surgery. Study of surgical anatomy (author's transl)]. 1976
1976 [Surgery of acute coronary insufficiency and its complications]. 1976
1975 [Aneurysms of the superior mesenteric artery. A case of aneurysm of the trunk of the superior mesenteric artery, probably of congenital origin]. 1975
1975 [Operation for stenosis of the internal carotid artery secondary to irradiation (a propos of 1 observation)]. 1975
1975 Radiogenic internal carotid stenosis. Report of operated case 1975
1974 Aneurysma dilatation of pulmonary veins due to mitral insufficiency. A rare case of mediastinal tumor 1974

Book

Year Title Altmetric
2008 Handbook of cardiac stem cell therapy 2008

Chapter

Year Title Altmetric
2015 Safety, regulatory, and ethical issues of human studies.  309-323. 2015
2014 Human embryonic stem cells (hESCs) for heart regeneration.  266-296. 2014
2014 The Need for Immune Modulation Despite Regenerative Medicine.  935-944. 2014
2013 Cellular cardiomyoplasty and stem cell therapy.  133-145. 2013
2008 Skeletal myoblast transplantation for ischemic heart failure.  189-202. 2008
2007 Cell transplantation in chronic heart failure: Proof of concept and early clinical experience.  181-193. 2007
2006 Skeletal myoblasts: The European experience.  95-104. 2006
2004 Cellular transplantation.  545-560. 2004

Full Name

  • Philippe Menasche